Cardiotoxicity is one of the leading causes of drug attrition during development, and accounts for 22-28% of US post-marketing drug withdrawal. Therefore, developing sensitive in vitro assays assessing drug-induced cardiotoxicity in preclinical and early clinical stages is especially important for drug development.
The TargetMol’s Cardiotoxicity Compound Library, a unique collection of 132 cardiotoxicity inducing compounds, can be used for chemical toxicity evaluation and prediction.
Pack Size | Price/USD |
---|---|
100 μL * 10 mM (in DMSO) | 2183.00 |
250 μL * 10 mM (in DMSO) | 3672.00 |
1 mg | 3672.00 |